Photo courtesy AstraZeneca

Oxford’s COVID-19 vaccine ‘highly effective,’ trials show

1 min read

A COVID-19 vaccine being developed by the University of Oxford and British pharmaceutical company AstraZeneca was found to have an average efficacy rate of 70 percent following a large-scale trial.

The trial involved two separate dosing regimens, one which showed a 90 percent efficacy rate, and the other with 62 percent.

Professor Andrew Pollard, Director of the Oxford Vaccine Group and Chief Investigator of the Oxford Vaccine Trial, said the results “show that we have an effective vaccine that will save many lives.”

The Oxford vaccine is said to be cheaper, requires simpler storage and is easier to transport than those developed by Pfizer and Moderna.

Clark Kent

Clark Kent came to the city of Metropolis to study journalism at Metropolis University. After graduation, Clark took a job at the Daily Planet as a reporter. Under the direction of editor-in-chief Perry White, he quickly gained a reputation as a journalist who was unafraid to cover the injustices of the city, including its political corruption .

Leave a Reply

Previous Story

‘Last of Us’ TV show green-lit at HBO

Next Story

Trump administration grants permission to begin Biden transition process

Latest from Health & Wellness